Compare BBSI & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BBSI | PSNL |
|---|---|---|
| Founded | 1965 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Professional Services | Medical Specialities |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 711.6M | 729.1M |
| IPO Year | 1994 | 2019 |
| Metric | BBSI | PSNL |
|---|---|---|
| Price | $27.65 | $6.79 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $42.67 | $11.50 |
| AVG Volume (30 Days) | 314.4K | ★ 1.4M |
| Earning Date | 05-28-2026 | 05-18-2026 |
| Dividend Yield | ★ 1.16% | N/A |
| EPS Growth | 5.05 | ★ 33.58 |
| EPS | ★ 2.08 | N/A |
| Revenue | ★ $920,432,000.00 | $69,648,000.00 |
| Revenue This Year | $8.20 | $16.94 |
| Revenue Next Year | $6.04 | $36.58 |
| P/E Ratio | $13.22 | ★ N/A |
| Revenue Growth | ★ 9.50 | N/A |
| 52 Week Low | $25.33 | $2.83 |
| 52 Week High | $49.65 | $11.50 |
| Indicator | BBSI | PSNL |
|---|---|---|
| Relative Strength Index (RSI) | 33.70 | 35.07 |
| Support Level | $25.33 | $4.31 |
| Resistance Level | $29.49 | $6.94 |
| Average True Range (ATR) | 1.13 | 0.70 |
| MACD | 0.08 | -0.20 |
| Stochastic Oscillator | 34.28 | 7.14 |
Barrett Business Services Inc is a provider of payroll administrative services and staffing services. The company categories of services include professional employer services and staffing. Professional employer services offer payroll management, payroll tax services, and workers' compensation coverage solutions, as well as workforce management services, including hiring and termination of employees. Staffing offers temporary staffing services, as well as contract staffing, long-term or indefinite on-site management, and direct placement services. The company operates in the United States of America. It generates maximum revenue from the Professional employer service fees.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.